Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells

Cancer Research

Volumn 60, Issue 2, 2000, Pages 262-265

  Shin, Jong Yeon ^a   Kim, Hyun Seok ^a   Park, Jinseu ^a   Park, Jae Bong ^a   Lee, Jae Yong ^a,b  

^a Hallym University   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE DEACETYLASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRICHOSTATIN A;

ARTICLE; CANCER CELL; DNA METHYLATION; ENZYME INHIBITION; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

AZACITIDINE; BUTYRIC ACID; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR P57; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034650338     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Norbury, C., and Nurse, D. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
2. Marx, J. How cells cycle toward cancer. Science (Washington DC), 263: 319-321, 1994.
3. Elledge, S. J., Winston, J., and Harper, J. W. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol., 6: 388-392, 1996.
4. 1 cyclin-dependent kinase. Genes Dev., 9: 1149-1163, 1995.
5. Hall, M., Bates, S., and Peters, G. Evidence for different mode of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinase, p21 and p27 bind to cyclins. Oncogene., 11: 1581-1588, 1995.
6. CIP1. Mol. Cell. Biol., 16: 4673-4682, 1996.
7. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
8. Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
9. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
10. KIP1 expression is inversely proportional to the proliferative index. Am. J. Pathol., 151: 151-159, 1997.
11. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA, 95: 6791-6796, 1998.
12. Archer, S. Y., and Hodin, R. A. Histone acetylation and cancer. Curr. Opin. Genet. Dev., 9: 171-174, 1999.
13. Issa, J-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of estrogen receptor CpG island links aging and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
14. Laird, P. W., and Jaenisch, R. DNA methylation and cancer. Hum. Mol. Genet., 3: 1487-1495, 1994.
15. Jones, P. A., and Taylor, S. M. Cellular differentiation, cytidine analogs, and DNA methylation. Cell, 20: 85-93, 1980.
16. Park, J. G., Frucht, H., LaRocca, R. V., Bliss, D. B., Jr., Kurita, Y., Chen, T-R., Henslee, J.G., Trepel, J. B., Jensen, R. T., Johnson, B. E., Bang, Y-J., Kim, J-P., and Gazdar, A. F. Characteristics of cell lines established from human gastric carcinoma. Cancer Res., 50: 2773-2780, 1990.
17. Park, J. G., Yang, H-K., Kim, W. H., Chung, J-K., Kang, M-S., Lee, J-H., Oh, J-H., Park, H-S., Yeo, K-S., Kang, S-H., et al. Establishment and characterization of human gastric carcinoma cell lines. Int. J. Cancer, 70: 443-449, 1997.
18. Sekiguchi, M., Sakakibara, K., and Fujii, G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med., 48: 61-68, 1978.
19. Dehia, P. L., Aguiar, R. C., Honeggar, J., Fahlbush, R., Jordan, S., Lowe, D. G., Lu, X., Clayton, R. N., Besser, G. M., and Grossman, A. B. Mutation and expression analysis of the p27/KIP1 gene in corticotrophin-secreting tumors. Oncogene 16: 69-76, 1998.
20. 2. Mol. Cell. Biol., 16: 414-421, 1996.
21. 2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481, 1997.
22. 2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol. Cell. Biol., 18: 5492-5499,1998.
23. Boyes, J., and Bird, A. P. DNA-methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64: 1123-1134, 1991.
24. Hendrich, B., and Bird, A. P. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18: 6525-6537, 1998.
25. Hsieh, C. L. Evidence that protein binding specifies sites of DNA demethylation. Mol. Cell. Biol., 19: 46-56, 1996.